Thomson Reuters | GenomeWeb

Thomson Reuters

Six US agencies made Thomson Reuters' list of most innovative government research institutions.

Nobel Gazing

Thomson Reuters predicts that the developers of the CRISPR/Cas9 genome editing approach may win the Nobel Prize in Chemistry.

Thomson Reuters has launched a new product called the Clinical Genomics Toolkit that bundles curated content from relevant public repositories as well as the company's own proprietary databases and internally developed analytic algorithms.

NEW YORK (GenomeWeb) – GenoSpace has received an undisclosed financial investment from Thomson Reuters that it will use to expand its customer base in research, clinical development, laboratory medicine, and clinical care.

This week, Thomson Reuters launched Cortellis Data Fusion, an addition to the company's Cortellis suite, which provides access to information for drug discovery and development.

Because most pure-play bioinformatics companies aren't publicly traded, the sector doesn’t have the financial barometer that things like quarterly earnings reports provide, making it somewhat challenging to gauge growth and speculate about future gains.

Tohoku University's Tohoku Medical Megabank Organization (ToMMo) is using informatics solutions from Thomson Reuters to support a large-scale genome research project aimed at furthering personalized medicine efforts.

Thomson Reuters and NuMedii this week announced a partnership that will pair NuMedii's underlying informatics technology with curated drug and disease information and systems biology expertise from Thomson Reuters for use in identifying new applications for existing drugs.

Last week, Thomson Reuters said that it had purchased Entagen, a privately-owned informatics company that offers semantic search and navigation software and custom development services to pharmaceutical, biotechnology, and laboratory automation companies, for an undisclosed amoun

Certara said this week that it is partnering with Thomson Reuters to provide customers of its D360 software solution with access to content contained in Thomson Reuters' Cortellis for Informatics system.

Pages

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.